| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |